Termgrid is delighted to announce that it is continuing its support for Leveraged Finance Fights Melanoma (LFFM) by becoming a preferred sponsor for its annual New York event.
The New York event has so far raised $27m to support the work of the Melanoma Research Alliance (MRA), the largest non-profit funder of melanoma research in the world. Funds raised have been vital in furthering the fight against melanoma and other cancers – with drugs first approved in melanoma now being tested in more than 30 cancers.
The event will take place on June 11, 2025 at the Museum of Modern Art. It is the premier gathering for leaders in leveraged finance private equity and investment communities.
Earlier this year, the LFFM expanded its fundraising events with its inaugural London event – raising a total of $1.6m.
“It is a privilege to stand alongside such an extraordinary community brought together by the LFFM in the fight against melanoma. We’ve witnessed the strength and unity of this cause in London, and we are now honored to support it in New York” said Dipish Rai, CEO, Termgrid.
For enquires about sponsoring this event, please visit the MRA website.
Stay in touch with all of our latest updates and articles. Sign up now.